Borosil Scientific Limited (BOROSCI) Fair Value & Analysis
Consumer Cyclical · IN · Market cap ₹14.8B (≈ $157M) · ISIN INE02L001032
What is Borosil Scientific Limited really worth?
A solid business, but trading 62% above our fair value of ₹81.72.
As of Aug 28, 2026, the fair value of Borosil Scientific Limited is ₹81.72 per share against a price of ₹132.15, so the fair value sits 38% below the price. A model estimate blended from multiple valuation models, recalculated regularly.
Strengths
Risks
Fair value as of: Aug 28, 2026
From 24 valuation models · updated 9 days ago
Fair value updated Aug 28, 2026, revised from ₹83.82 to ₹81.72 (−2.5%) since Aug 13, 2026. Share price −5.7% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (₹102.15). The favourable scenario is already priced in.
- Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (₹43.24 to ₹102.15) leaves room in how you read the outcome.
Price vs Fair Value (2 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 28, 2026.
How to read this chart
27‑month range ₹101.35 – ₹223.95 · fair‑value band ₹43.24 – ₹102.15 · the ₹132.15 price screens above the ₹81.72 fair value. Dashed = 300-day average. As of Aug 28, 2026.
Analysis
Borosil Scientific Limited (BOROSCI) currently trades at ₹132.15, while our model-based Fair Value estimate is ₹81.72, implying the stock looks roughly 61.7% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Consumer Cyclical sector. Bull case: the Growth Earnings group reads highest at a median of ₹178.15 per share, and 5 of the 24 models we run sit above the ₹132.15 price. Bear case: the Asset-Based group reads lowest at ₹33.24, and 19 of the 24 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, Borosil Scientific Limited generated revenue of ₹4.7B at a net margin of 7.4%. Revenue grew 10.6% year over year. It earns a return on equity of 8.2%. Net debt stands at ₹8.0M. Fundamentals as of Aug 28, 2026
Our scenario range runs from ₹43.24 (bear case) to ₹102.15 (bull case); at ₹132.15, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 31% below its 52-week high and 37% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at −39% fair-value upside, at −38%, BOROSCI screens cheaper than that median.
Fair Value models
This estimate rests on fiscal year 2026 figures, and about 5 months have passed since. In that time the company retained roughly ₹1.69 per share, which is 2.1 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 24 models by family
Widest divergence: Growth Earnings (₹178.15) versus Asset-Based (₹33.24). Highest evidence: EPV (71).
Notify me when BOROSCI reaches fair value
Put BOROSCI on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 28, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 55 · Market factors (momentum, volatility) 47
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Borosil Scientific Limited manufactures and sells laboratory glassware. It offers glassware and consumables, including lab glassware, filtration products, analytical vials, and lab accessories for use in pharmaceutical, food and soil testing, microbiology, and biotechnology industries; laboratory equipment for use in nutrition and environment, life …
Full company description
Borosil Scientific Limited manufactures and sells laboratory glassware. It offers glassware and consumables, including lab glassware, filtration products, analytical vials, and lab accessories for use in pharmaceutical, food and soil testing, microbiology, and biotechnology industries; laboratory equipment for use in nutrition and environment, life sciences, liquid handling, and laboratory equipment applications; pharmaceutical primary packaging materials, such as glass ampoules and tubular glass vials; and process science products comprising lab reactors, industrial reactors, lab rotary evaporators, and industrial rotary evaporators. The company was formerly known as Klass Pack Limited and changed its name to Borosil Scientific Limited in December 2023. The company was founded in 1962 and is based in Mumbai, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Borosil Scientific Limited reported revenue of ₹4.7B in FY2026 versus ₹1.1B in FY2022, a compound +44.8%/yr. Reported net income was ₹346M in FY2026, compounding +41.8%/yr from FY2022.
BOROSCI screens 62% overvalued. Compare with Smurfit Westrock Plc, →
Peer Group
Packaging & Containers · 271 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaging & Containers median · lower = cheaper
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Packaging & Containers stocks, each showing price versus our Fair Value estimate (as of Aug 28, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Smurfit Westrock Plc, SW | $49.25 | $22.66 | −54% |
| Packaging Corporation PKG | $233.94 | $122.63 | −48% |
| International Paper Company IP | $36.46 | $21.44 | −41% |
| Amcor plc AMCR | $45.15 | $18.79 | −58% |
| Ball Corporation BALL | $61.67 | $36.57 | −41% |
| Crown Holdings CCK | $119.08 | $118.59 | +0% |
| Avery Dennison Corporation AVY | $173.07 | $113.05 | −35% |
| CCL Industries Inc CCLA | C$93.99 | C$77.64 | −17% |
| Stora Enso Oyj STEAV | €9.74 | €11.42 | +17% |
| SIG Group SIGN | CHF 13.66 | CHF 8.32 | −39% |
Compare Borosil Scientific Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Borosil Scientific Limited (BOROSCI) overvalued or undervalued?
What is the fair value of BOROSCI?
What is the quality score of BOROSCI?
What is the price target for Borosil Scientific Limited (BOROSCI)?
What is the Borosil Scientific Limited stock forecast for 2026?
What is the revenue of Borosil Scientific Limited (BOROSCI)?
What is the net profit margin of BOROSCI?
Watch Borosil Scientific Limited in the live analysis
One click puts Borosil Scientific Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.